NCT04752891

Brief Summary

Otitis media (OM) is one of the most common childhood infections and is a major cause of morbidity in children and results as being the first cause of antibiotic prescription among children in developed countries . An artificial intelligence-based tool could help physicians refine their diagnosis

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
203

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 12, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

June 10, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 16, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 16, 2023

Completed
Last Updated

March 17, 2023

Status Verified

March 1, 2023

Enrollment Period

1.2 years

First QC Date

February 2, 2021

Last Update Submit

March 16, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • diagnosis of purulent Acute Otitis Media (AOM) made by junior physicians using the i-Nside application associated with Smartscope®

    diagnosis of purulent AOM is made on an inflammatory aspect of the eardrum with retrotympanic effusion, exteriorized (otorrhea) or not (opacity, effacement of reliefs or bulging, disappearance of the light triangle).

    at inclusion

  • diagnosis of purulent Acute Otitis Media (AOM) made by senior physicians using a standard otoscope

    diagnosis of purulent AOM is made on an inflammatory aspect of the eardrum with retrotympanic effusion, exteriorized (otorrhea) or not (opacity, effacement of reliefs or bulging, disappearance of the light triangle)

    at inclusion

Secondary Outcomes (3)

  • rate of misdiagnoses of purulent Acute Otitis Media (AOM) with and without the use of the application

    at inclusion

  • collection risk factors for a discrepancy in the diagnosis of purulent AOM

    at inclusion

  • satisfaction of junior physicians regarding the use of the app

    through study completion, an average of 1 year

Study Arms (2)

AOM diagnosis with app

EXPERIMENTAL
Other: AOM diagnosis with app

AOM diagnosis without app

OTHER
Other: AOM diagnosis without app

Interventions

the diagnosis made by a senior physician using a traditional otoscope. the diagnosis made by the junior physician using an otoendoscope fixed on a connected smartphone

AOM diagnosis with app

the diagnosis made by a senior physician and by the junior physician, using a traditional otoscope

AOM diagnosis without app

Eligibility Criteria

AgeUp to 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Child under 18 years Presenting signs that may suggest acute otitis media (fever, earache, purulent otorrhea) For which the informed written consent of, at least, one of the two parents or the holder of parental authority has been obtained

You may not qualify if:

  • A sign (s) of vital distress Trans-tympanic drains

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpitaux Pédiatrique de Nice CHU Lenval

Nice, France

Location

MeSH Terms

Conditions

Otitis Media, Suppurative

Interventions

Amyloid

Condition Hierarchy (Ancestors)

SuppurationInfectionsOtitis MediaOtitisEar DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

Multiprotein ComplexesMacromolecular SubstancesProteinsAmino Acids, Peptides, and Proteins

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2021

First Posted

February 12, 2021

Study Start

June 10, 2021

Primary Completion

August 16, 2022

Study Completion

March 16, 2023

Last Updated

March 17, 2023

Record last verified: 2023-03

Locations